BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28694140)

  • 1. miRNAs in B Cell Development and Lymphomagenesis.
    Coffre M; Koralov SB
    Trends Mol Med; 2017 Aug; 23(8):721-736. PubMed ID: 28694140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LymphomiRs: microRNAs with regulatory roles in lymphomas.
    Kozloski GA; Lossos IS
    Curr Opin Hematol; 2015 Jul; 22(4):362-8. PubMed ID: 26049758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential.
    Kersy O; Salmon-Divon M; Shpilberg O; Hershkovitz-Rokah O
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in B cell development and malignancy.
    Fernando TR; Rodriguez-Malave NI; Rao DS
    J Hematol Oncol; 2012 Mar; 5():7. PubMed ID: 22401860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
    Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
    Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germinal Centre B Cell Functions and Lymphomagenesis: Circuits Involving MYC and MicroRNAs.
    Robaina MC; Mazzoccoli L; Klumb CE
    Cells; 2019 Oct; 8(11):. PubMed ID: 31683676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and lymphomagenesis: a functional review.
    Lawrie CH
    Br J Haematol; 2013 Mar; 160(5):571-81. PubMed ID: 23205669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma.
    Maute RL; Schneider C; Sumazin P; Holmes A; Califano A; Basso K; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1404-9. PubMed ID: 23297232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies.
    Malaney P; Velasco-Estevez M; Aguilar-Garrido P; Aitken MJL; Chan LE; Zhang X; Post SM; Gallardo M
    Front Immunol; 2021; 12():634584. PubMed ID: 33912162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
    Musilova K; Mraz M
    Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
    Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
    Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.
    Sperling S; Fiedler P; Lechner M; Pollithy A; Ehrenberg S; Schiefer AI; Kenner L; Feuchtinger A; Kühn R; Swinerd G; Schmidt-Supprian M; Strobl LJ; Zimber-Strobl U
    Blood; 2019 Jun; 133(24):2597-2609. PubMed ID: 30962205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of microRNAs in malignant transformation.
    Rutnam ZJ; Yang BB
    Histol Histopathol; 2012 Oct; 27(10):1263-70. PubMed ID: 22936445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma and the control of B cell growth and differentiation.
    Rui L; Goodnow CC
    Curr Mol Med; 2006 May; 6(3):291-308. PubMed ID: 16712476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.
    Tao J; Zhao X; Tao J
    Cell Cycle; 2014; 13(2):191-8. PubMed ID: 24394940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.
    Marques SC; Laursen MB; Bødker JS; Kjeldsen MK; Falgreen S; Schmitz A; Bøgsted M; Johnsen HE; Dybkaer K
    Oncotarget; 2015 Jan; 6(1):7-25. PubMed ID: 25622103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.
    Contreras JR; Palanichamy JK; Tran TM; Fernando TR; Rodriguez-Malave NI; Goswami N; Arboleda VA; Casero D; Rao DS
    Oncotarget; 2015 May; 6(13):11023-37. PubMed ID: 25906746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in Normal and Malignant Hematopoiesis.
    Kotaki R; Koyama-Nasu R; Yamakawa N; Kotani A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28696359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.